MYGN
Myriad Genetics Inc
$5.69
0.16 (2.74%) Today
— up— down
Market Cap
$553M+7.5%
Revenue (TTM)
$835.64M-0.3%
Net Income (TTM)
$-407,617,865
$-407,617,865EPS (TTM)
-4.32
-4.32Shares Out
94.45M
94.45MForward P/E
48.31
48.31Open
$5.85
$5.85Previous Close
$5.85
$5.85Day Range
$5.55 – $5.93
$5.55 – $5.9352-Week Range
$3.53 – $8.59
$3.53 – $8.59Beta
1.59
1.59Volume
485.89K
485.89KAvg Volume
1.90M
1.90MAnalyst Rating
Hold
HoldExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout MYGN
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity.